Hey guys, how goes it? I would like you to take a good look at XOMA. It is a biotech spec play, that finally after being the first biotech co. on the nasdaq, and not bringing 1 product to mkt, finally has a drug in phase 2 trial. This co. is not only a buyout cantidate, but also has had and continues to have ties to big pharma, including Genentech, Pfiser, and others.
It could be a while off before a payoff, but if you do a little DD, I think you will start buying a little at a time.
I took a starter position there today. The mgt. is solid as Sears. And they always manage to generate enough cap. to continue.
Check it out, and see if you agree.
Market Data 
Markets 
AI
